company background image
I1QV34 logo

IQVIA Holdings BOVESPA:I1QV34 Stock Report

Last Price

R$319.45

Market Cap

R$229.0b

7D

5.2%

1Y

n/a

Updated

19 Jul, 2024

Data

Company Financials +

IQVIA Holdings Inc.

BOVESPA:I1QV34 Stock Report

Market Cap: R$229.0b

I1QV34 Stock Overview

Engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

I1QV34 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance4/6
Financial Health1/6
Dividends0/6

IQVIA Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IQVIA Holdings
Historical stock prices
Current Share PriceUS$319.45
52 Week HighUS$319.45
52 Week LowUS$225.40
Beta1.5
11 Month Change7.20%
3 Month Changen/a
1 Year Changen/a
33 Year Change2.18%
5 Year Changen/a
Change since IPO93.02%

Recent News & Updates

Recent updates

Shareholder Returns

I1QV34BR Life SciencesBR Market
7D5.2%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how I1QV34 performed against the BR Life Sciences industry.

Return vs Market: Insufficient data to determine how I1QV34 performed against the BR Market.

Price Volatility

Is I1QV34's price volatile compared to industry and market?
I1QV34 volatility
I1QV34 Average Weekly Movementn/a
Life Sciences Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in BR Market0%
10% least volatile stocks in BR Market0%

Stable Share Price: I1QV34 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine I1QV34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a87,000Ari Bousbibwww.iqvia.com

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc. Fundamentals Summary

How do IQVIA Holdings's earnings and revenue compare to its market cap?
I1QV34 fundamental statistics
Market capR$228.97b
Earnings (TTM)R$7.58b
Revenue (TTM)R$84.22b

30.2x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
I1QV34 income statement (TTM)
RevenueUS$15.07b
Cost of RevenueUS$9.79b
Gross ProfitUS$5.28b
Other ExpensesUS$3.92b
EarningsUS$1.36b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 22, 2024

Earnings per share (EPS)7.45
Gross Margin35.03%
Net Profit Margin9.01%
Debt/Equity Ratio213.6%

How did I1QV34 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.